Click to Return to Home Page
Log In | Register Now

       Help



















 


 


Metabolites in Urine
Isobaric compounds (creatine and 4-hydroxyproline) separated from other components of synthetic urine

charts

PDF
Click here to view
printable Application Sheet
Notes: Cr is a compound that is made primarily in the liver and then transported to muscles where it is used as an energy source. Once in the muscle, some of the Cr is spontaneously converted to Cm. It is important to monitor the Cr/Cm ratio. An increased ratio may be due to several diseases: congestive heart failure or dehydration. It may also be seen with gastrointestinal bleeding, or increased protein in the diet. The ratio may be decreased with liver disease (due to decrease in the formation of urea) and malnutrition. Cr and Cr analogs such as cyclocreatine were found to have antitumor, antiviral, and antidiabetic effects and to protect tissues from hypoxic, ischemic, neurodegenerative, or muscle damage.


Method Conditions


Column Cogent Diamond Hydride™, 4µm, 100A
Catalog No. 70000-7.5P
Dimensions 2.1 x 150 mm
Solvents A: DI water, 0.1% formic acid
B: Acetonitrile, 0.1% formic acid
Mobile Phase
Gradient
Time %B Time %B
0.0 95 35.0 50
0.2 95 35.1 95
30.0 50 40.0 95
Flow Rate 0.4 mL/min.
Sample Synthetic urine
Compounds
  1. Creatinine - Cm
    M+H 114.0662, RT = 11.98 min
  2. Creatine - Cr
    M+H 132.0768, RT = 12.52 min
  3. 4-Hydroxyproline
    M+H 132.0655, RT = 13.16 min
Detection ESI – pos - Agilent 6210 MSD TOF mass spectrometer


Discussion


Creatine and Creatinine are typically very difficult to separate from each other. A simple gradient with an MS friendly mobile phase was used to resolve these two compounds. In addition 4-hydroxyproline which has a very similar mass weight as creatine was also easily separated. A powerful combination of an Agilent MSD-TOF instrument (4 digit mass accuracy) and a Cogent Diamond Hydride™ LCMS column takes away guessing from the analysis of metabolites in a complex mixture as shown.






[TOP]


Privacy Statement             Copyright © 2005, MicroSolv Technology Corporation.             Site developed by Net Ink Designs.